Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Burgess

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccine|March 28, 2006
The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?David C Burgess, Margaret A Burgess, Julie Leask
The Medical Journal of Australia|July 17, 2003
Baseline data in clinical trialsDavid C Burgess, Val J Gebski, Anthony C Keech
European Heart Journal|October 4, 2006
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysisDavid C Burgess, Michael J Kilborn, Anthony C Keech
The Medical Journal of Australia|November 9, 2005
A systematic review and economic analysis of drug-eluting coronary stents available in AustraliaSarah J Lord, Kirsten Howard, Felicity Allen, et al.
The American Journal of Cardiology|February 16, 2010
Predictive value of ST resolution analysis performed immediately versus at ninety minutes after primary percutaneous coronary interventionSaurabh Kumar, Gopal Sivagangabalan, Calvin Hsieh, et al.
European Heart Journal|October 3, 2009
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyDavid C Burgess, David Hunt, Liping Li, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccine|March 28, 2006
The MMR vaccination and autism controversy in United Kingdom 1998-2005: inevitable community outrage or a failure of risk communication?David C Burgess, Margaret A Burgess, Julie Leask
The Medical Journal of Australia|July 17, 2003
Baseline data in clinical trialsDavid C Burgess, Val J Gebski, Anthony C Keech
European Heart Journal|October 4, 2006
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysisDavid C Burgess, Michael J Kilborn, Anthony C Keech
The Medical Journal of Australia|November 9, 2005
A systematic review and economic analysis of drug-eluting coronary stents available in AustraliaSarah J Lord, Kirsten Howard, Felicity Allen, et al.
The American Journal of Cardiology|February 16, 2010
Predictive value of ST resolution analysis performed immediately versus at ninety minutes after primary percutaneous coronary interventionSaurabh Kumar, Gopal Sivagangabalan, Calvin Hsieh, et al.
European Heart Journal|October 3, 2009
Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyDavid C Burgess, David Hunt, Liping Li, et al.
Pageof 1